Table 1.
Patient characteristics
| Variable | n (%) or mean [SD] |
|---|---|
| Age, years | 66 [9.4] |
| Male sex | 64 (79.0) |
| CT-stage† | |
| T2 | 23 (28.4) |
| T3 | 50 (61.7) |
| T4 | 8 (9.9) |
| CN-stage† | |
| N0 | 31 (38.3) |
| N1 | 36 (44.4) |
| N2-3 | 14 (17.3) |
| Tumor histology | |
| Adenocarcinoma | 79 (97.5) |
| Neuroendocrine carcinoma | 1 (1.2) |
| Manec | 1 (1.2) |
| Neoadjuvant Chemotherapy | |
| None | 8 (10.8) |
| Started, not completed | 12 (16.2) |
| Completed | 54 (73.0) |
| Type of operation | |
| Open | 46 (70.0) |
| Robot-assisted | 20 (30.0) |
| Surgical results | |
| R0 | 59 (89.4) |
| Non-resectable | 7 (10.6) |
Tumors were classified according to the 7th edition of TNM-classification[9]. †T/N stage evaluated by CT-scan at the primary diagnostic workup. Manec: mixed adenoneurocrine carcinoma